English
Français
Español
Deutsch
Italiano
Português
Nederlands
Polski
Română
Svenska
Dansk
Suomi
Čeština
Ελληνικά
Magyar
SlovenčinaData temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.
Investlytic score: 2/5 criteria met.
- ❌ Price trend failed
- ⚠️ Mixed growth
- ✅ Debt passed
- ❌ P/E failed
- ✅ Correction passed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2018 → 2019: -89.41%
Price change 2019 → 2020: -61.13%
Price change 2020 → 2021: -60.67%
Price change 2021 → 2022: -94.08%
Price change 2022 → 2023: -47.62%
Price change 2023 → 2024: -91.67%
Price change 2024 → 2025: -99.42%
Price change 2025 → 2026: -9.34%
Price change 2026 (year to date): -15.21%
Financial growth
Revenue CAGR (8 years): 43.59%
Earnings CAGR (8 years): N/A
Growth status: positive trend (>1%/yr) in revenue, earnings data insufficient/N/A.
Debt
Debt-to-equity ratio: 0.00
Debt/equity < 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: -0.09
P/E > 25.0 (maximum threshold).
Correction (6 months)
Current correction: 19.88% from the high over 6 months.
Correction between 10.0% and 20.0% (target range).
Criteria of the Investlytic model
- / 5Free with the Investlytic logo. Paste this line into your page: options.
<script src="https://investlytic.co/encart.js" data-symbole="HSDT" data-lang="en"></script>Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| Solana Company | – | 0.00 | – | 🔒 |
| Onward Medical N.V. | – | 0.25 | +34.5 % | – |
| Bastide Le Confort Médical S.A. | 20.1 | 5.70 | +10.3 % | – |
| Guerbet S.A. | – | 1.64 | +5.5 % | – |
| Euroapi S.A. | – | 0.08 | −1.3 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|
Key reported figures
Revenue, net income and net margin reported by Solana Company over the latest fiscal years.
| Fiscal year | Revenue | Net income | Net margin | Revenue growth |
|---|---|---|---|---|
| 2020 | 661,000 | -14.1 m | -2,137.7 % | n/a |
| 2021 | 522,000 | -18.1 m | -3,473.6 % | -21.0 % |
| 2022 | 787,000 | -14.1 m | -1,788.1 % | +50.8 % |
| 2023 | 644,000 | -8.8 m | -1,374.2 % | -18.2 % |
| 2024 | 520,000 | -11.7 m | -2,258.1 % | -19.3 % |
| 2025 | 6.0 m | -40.9 m | -679.6 % | +1,057.1 % |
Amounts converted to USD. Source: published annual accounts, collected on 06/11/2026.
Accounts and financial health
Balance sheet and cash flow published by Solana Company over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash and investments | 11.0 m | 14.5 m | 5.2 m | 1.1 m | 7.3 m |
| Total Debt | 3,000 | 110,000 | 57,000 | 12,000 | 0 |
| Net Debt | -11.0 m | -14.4 m | -5.1 m | -1.1 m | -7.3 m |
| Equity | 11.3 m | 8.2 m | 2.4 m | 1.1 m | 301 m |
| Total assets | 14.1 m | 17.3 m | 7.7 m | 3.5 m | 304 m |
| Operating cash flow | -13.4 m | -14.3 m | -10.4 m | -11.0 m | -16.5 m |
| Investments (capex) | 56,000 | 17,000 | 29,000 | 5,000 | 44.8 m |
| Free cash-flow | -13.4 m | -14.3 m | -10.4 m | -11.0 m | -61.3 m |
| Share buybacks | 0 | 0 | 0 | 0 | 0 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 |
Amounts in USD, currency of the published accounts.
Trailing 12-month ratios
Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 09/11/2026.
Analyst consensus and forecasts
What the financial analysts covering Solana Company publish: ratings, price targets and earnings forecasts.
Breakdown of ratings
Price targets: published for companies listed in the United States only.
Track record against expectations: reported EPS above consensus 7 times over the last 12 releases.
Source: ratings and forecasts published by analysts, collected on 07/11/2026. An analyst rating or target is not a guarantee.
PEA and practical information
Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.
Frequently asked questions about Solana Company
What is the Solana Company share price?
Latest recorded price: 1.93 USD on 06/11/2026, for a market cap of 113 m USD.
What is the revenue of Solana Company?
6.0 m USD for fiscal year 2025, with net income of -40.9 m USD (net margin -679.6 %).
What do analysts say about Solana Company?
Out of 5 analysts: 3 buy or strong buy, 2 hold, 0 sell or strong sell.
Is Solana Company stock eligible for the French PEA?
No: the company is headquartered outside the European Union and the European Economic Area (ISIN US42328V8761).
How many employees does Solana Company have?
21 full-time employees according to the latest published profile.
Who runs Solana Company?
Dane Carl Andreeff is the company's chief executive.